Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map red Filtered green network_comparison
Results: HTML CSV LaTeX Showing element 1980 to 2029 of 6456 in total 
Value Type: Ranked
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
990\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atrophin-1 interacting protein 1; activin receptor interacting protein 1; likely ortholog of mouse activin receptor interacting protein 1; atrophin-1 interacting protein a; membrane associated guanylate kinase 2; activin receptor interacting p. [source:refseq;acc:nm\_012301]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.682\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
228.68\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.998\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
991\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dolichol-phosphate mannosyltransferase (ec 2.4.1.83) (dolichol- phosphate mannose synthase) (dolichyl-phosphate beta-d- mannosyltransferase) (mannose-p-dolichol synthase) (mpd synthase) (dpm synthase). [source:swissprot;acc:o60762]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.381\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
196.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03365\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
polymyositis/scleroderma autoantigen 2 (autoantigen pm/scl 2) (polymyositis/scleroderma autoantigen 100 kda) (pm/scl-100) (p100 polymyositis-scleroderma overlap syndrome associated autoantigen). [source:swissprot;acc:q01780]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
198.494\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
205.466\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.972\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
992\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine protease htra1 precursor (ec 3.4.21.-) (l56). [source:swissprot;acc:q92743]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.468\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.357\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03364\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vinculin (metavinculin). [source:swissprot;acc:p18206]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
208.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.97\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
993\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocyte nuclear factor 4-gamma (hnf-4-gamma). [source:swissprot;acc:q14541]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
251.863\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
258.829\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.966\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pinin, desmosome associated protein; pinin. [source:refseq;acc:nm\_002687]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.071\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.205\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03362\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
994\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
growth arrest and dna-damage-inducible protein gadd45 gamma (cytokine responsive protein cr6). [source:swissprot;acc:o95257]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
251.863\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
258.829\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.966\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
poly(a) polymerase gamma (ec 2.7.7.19) (pap gamma) (polynucleotide adenylyltransferase gamma) (srp rna 3' adenylating enzyme). [source:swissprot;acc:q9bwt3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
116.845\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
120.772\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03361\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
995\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
growth arrest and dna-damage-inducible protein gadd45 alpha (dna- damage inducible transcript 1) (ddit1). [source:swissprot;acc:p24522]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
251.863\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
258.829\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.966\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitotic spindle assembly checkpoint protein mad2b (mad2-like 2) (hrev7). [source:swissprot;acc:q9ui95]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.656\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.547\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03345\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
996\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocyte nuclear factor 4-alpha (hnf-4-alpha) (transcription factor hnf-4) (transcription factor 14). [source:swissprot;acc:p41235]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
251.863\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
258.829\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.966\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial 28s ribosomal protein s32 (s32mt) (mrp-s32) (ptd007) (hspc204). [source:swissprot;acc:q9y6g3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.656\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.547\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03345\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
997\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
growth arrest and dna-damage-inducible protein gadd45 beta (negative growth-regulatory protein myd118) (myeloid differentiation primary response protein myd118). [source:swissprot;acc:o75293]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
251.863\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
258.829\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.966\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear pore complex protein nup88 (nucleoporin nup88) (88 kda nuclear pore complex protein). [source:swissprot;acc:q99567]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.656\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.547\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03345\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
998\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dynein intermediate chain 2, cytosolic (dh ic-2) (cytoplasmic dynein intermediate chain 2). [source:swissprot;acc:q13409]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
225.557\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.271\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03338\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosinase-related gene segment, exon 5 (fragment). [source:sptrembl;acc:q15677]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.302\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.409\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.893\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
999\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
skeletal muscle lim-protein 3 (slim 3) (lim-domain protein dral) (four and a half lim domains protein 2) (fhl-2). [source:swissprot;acc:q14192]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
269.608\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
276.493\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.885\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vinculin (metavinculin). [source:swissprot;acc:p18206]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
208.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03336\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1000\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal carnitine octanoyltransferase (ec 2.3.1.-) (cot). [source:swissprot;acc:q9ukg9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.523\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.648\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.875\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sprouty homolog 4 (spry-4). [source:swissprot;acc:q9c004]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.167\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.922\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03325\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1001\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dopachrome tautomerase precursor (ec 5.3.3.12) (dt) (dct) (dopachrome delta-isomerase) (tyrosinase-related protein 2) (trp-2) (trp2). [source:swissprot;acc:p40126]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.409\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.871\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sprouty homolog 3 (spry-3). [source:swissprot;acc:o43610]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.167\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.922\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03325\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1002\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
5,6-dihydroxyindole-2-carboxylic acid oxidase precursor (ec 1.14.18.-) (dhica oxidase) (tyrosinase-related protein 1) (trp-1) (trp1) (trp) (catalase b) (glycoprotein-75) (melanoma antigen gp75). [source:swissprot;acc:p17643]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.278\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.409\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.869\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sprouty homolog 1 (spry-1) (fragment). [source:swissprot;acc:o43609]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.167\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.922\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03325\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1003\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
pinin, desmosome associated protein; pinin. [source:refseq;acc:nm\_002687]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.071\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.205\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.866\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sprouty homolog 2 (spry-2). [source:swissprot;acc:o43597]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.167\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.922\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03325\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1004\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
sh2 domain binding protein 1; tpr-containing, sh2-binding phosphoprotein. [source:refseq;acc:nm\_014633]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
238.725\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
231.059\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03318\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
skeletal muscle lim-protein 2 (slim 2) (four and a half lim domains protein 3) (fhl-3). [source:swissprot;acc:q13643]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
269.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
276.454\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.864\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1005\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dynein intermediate chain 1, cytosolic (dh ic-1) (cytoplasmic dynein intermediate chain 1). [source:swissprot;acc:o14576]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.448\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.232\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03307\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dyskerin (nucleolar protein nap57) (cbf5 homolog). [source:swissprot;acc:o60832]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
231.007\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
237.864\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.857\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1006\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage and polyadenylation specificity factor, 73 kda subunit (cpsf 73 kda subunit). [source:swissprot;acc:q9ukf6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
116.524\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
120.375\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03305\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
retinoblastoma-like protein 2 (130 kda retinoblastoma-associated protein) (prb2) (p130) (rbr-2). [source:swissprot;acc:q08999]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.026\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.189\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.837\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1007\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ral guanine nucleotide dissociation stimulator (ralgef) (ralgds). [source:swissprot;acc:q12967]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
162.055\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
156.884\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03296\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
retinoblastoma-like protein 1 (107 kda retinoblastoma-associated protein) (prb1) (p107). [source:swissprot;acc:p28749]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.021\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.185\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.836\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1008\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna damage binding protein 1 (damage-specific dna binding protein 1) (ddb p127 subunit) (ddba) (uv-damaged dna-binding protein 1) (uv-ddb 1) (xeroderma pigmentosum group e complementing protein) (xpce) (x- associated protein 1) (xap-1). [source:swissprot;acc:q16531]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
222.364\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.535\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.829\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
wd-repeat protein bing4. [source:swissprot;acc:o15213]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
243.227\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.475\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03292\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1009\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dihydropyrimidine dehydrogenase [nadp+] precursor (ec 1.3.1.2) (dpd) (dhpdhase) (dihydrouracil dehydrogenase) (dihydrothymine dehydrogenase). [source:swissprot;acc:q12882]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
229.116\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.823\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03288\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
propionyl-coa carboxylase beta chain, mitochondrial precursor (ec 6.4.1.3) (pccase beta subunit) (propanoyl-coa:carbon dioxide ligase beta subunit). [source:swissprot;acc:p05166]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.364\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.535\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.829\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1010\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ataxin 2 related protein isoform a; ataxin-2 domain protein. [source:refseq;acc:nm\_007245]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
228.105\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.293\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.812\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal carnitine octanoyltransferase (ec 2.3.1.-) (cot). [source:swissprot;acc:q9ukg9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.523\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.648\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03264\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1011\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ataxin 2; olivopontocerebellar ataxia 2, autosomal dominant. [source:refseq;acc:nm\_002973]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.105\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.293\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.812\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
retinoblastoma-like protein 2 (130 kda retinoblastoma-associated protein) (prb2) (p130) (rbr-2). [source:swissprot;acc:q08999]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.026\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.189\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03253\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1012\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin alpha-4 subunit (karyopherin alpha-4 subunit) (qip1 protein). [source:swissprot;acc:o00629]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.369\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.561\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.808\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
retinoblastoma-like protein 1 (107 kda retinoblastoma-associated protein) (prb1) (p107). [source:swissprot;acc:p28749]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.021\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.185\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03252\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1013\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein bap28. [source:swissprot;acc:q9h583]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
244.312\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
236.647\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03239\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
target of egr1, member 1 (nuclear); target of egr1, member 1. [source:refseq;acc:nm\_025077]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.365\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.558\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.807\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1014\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
apoptosis antagonizing transcription factor. [source:refseq;acc:nm\_012138]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
243.045\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.422\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03238\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
importin alpha-3 subunit (karyopherin alpha-3 subunit) (srp1-gamma). [source:swissprot;acc:o00505]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.361\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.554\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.807\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1015\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bai1-associated protein 1; ww domain-containing protein 3; atrophin-1 interacting protein 3. [source:refseq;acc:nm\_004742]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
228.906\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03236\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/